JARID1A/1B inhibitors (Celgene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJARID1A/1B inhibitors (Celgene)
Drug Alias NameQC-3611
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 5A inhibitorsLysine-specific demethylase 5B inhibitors
TargetsLysine-specific demethylase 5BLysine-specific demethylase 5A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A